Metformin May Slow Emphysema Progression, Systemic Consequences
Metformin has demonstrated potential for slowing emphysema progression and its systemic consequences.
Chronic Obstructive Pulmonary Disease
Single-Inhaler Triple Therapy Reduces Composite AE Risk vs Dual Therapy in COPD
Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations.
Addressing the Controversy of “Pre-COPD”: A Point/Counterpoint Q&A
MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.
Triple Therapy Combination Reduces COPD Exacerbations, Death Risk
Patients with moderate to very severe COPD who received triple fixed doses of an inhaled glucocorticoid, LAMA, and LABA had fewer exacerbations compared with those taking 2 of the 3 medications.
Asthma, COPD Medication Adherence Increased During Pandemic
Medication adherence for asthma and COPD has increased during the COVID-19 pandemic.
COPD Independent Risk Factor for Lung Cancer
Chronic obstructive pulmonary disease (COPD) is an independent risk factor for lung cancer incidence, regardless of smoking status.
Antibiotics, Corticosteroids Beneficial in COPD Exacerbations
For adults with exacerbation of chronic obstructive pulmonary disease, antibiotics and systemic corticosteroids are associated with less treatment failure.
COPD Prevalence, Diagnosis, and Mortality: Differences Between Women and Men
Women were more likely than men to be diagnosed with chronic obstructive pulmonary disease, and had more frequent exacerbations.
Could COPD Serve as a Marker of Cardiovascular Morbidity, Mortality?
Patients with chronic obstructive pulmonary disease experience significant cardiovascular morbidity and mortality.
COPD Severity Affected by Traffic-Related Air Pollution
Acute exposure to traffic-related air pollution can lead to lower airway neutrophils to release of neutrophil extracellular traps, which is linked to COPD severity and airflow limitations.
- Loading...
Loading...
Loading... 
Loading...